When is it safe to jump ship?

Posted 11 September 2024 AM

The Australian biopharma space is seeing significant success, but even so there is the ever-present risk of drugs failing before they're medicines are commercialised. So when is it safe to make the jump from Big Pharma to a local company?

"The stage where most of the attrition happens is in phase two, where the likelihood of going from phase two into phase three is way less than 50 per cent," OneVentures founding partner, Dr Paul Kelly, told Pharma in Focus. OneVentures is a venture capital firm with a strong history supporting healthcare and biotech innovations.

To see the whole article, please login